Literature DB >> 31463091

Sometimes neither water nor fire are more useful than friendship-a new risk score for prediction of contrast-induced nephropathy (CIN) and long-term adverse outcomes in patients undergoing coronary angiography.

Ovidio De Filippo1, Fabrizio D'Ascenzo1, Francesco Piroli1, Carlo Budano1, Gaetano Maria De Ferrari1.   

Abstract

Entities:  

Year:  2019        PMID： 31463091      PMCID： PMC6688012          DOI： 10.21037/jtd.2019.06.51

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

Review 1.  Risk prediction of contrast-induced nephropathy.

Authors:  Peter A McCullough; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Fulvio Stacul; James Tumlin
Journal:  Am J Cardiol       Date:  2006-02-23       Impact factor: 2.778

2.  Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony.

Authors:  Marco Ranucci; Serenella Castelvecchio; Lorenzo Menicanti; Alessandro Frigiola; Gabriele Pelissero
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

3.  The ACEF score as predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention.

Authors:  Giuseppe Andò; Gaetano Morabito; Cesare de Gregorio; Olimpia Trio; Francesco Saporito; Giuseppe Oreto
Journal:  Int J Cardiol       Date:  2013-05-24       Impact factor: 4.164

Review 4.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

5.  Hospital-acquired renal insufficiency.

Authors:  Kevin Nash; Abdul Hafeez; Susan Hou
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

6.  Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study.

Authors:  M W Rich; C A Crecelius
Journal:  Arch Intern Med       Date:  1990-06

7.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency.

Authors:  Glenn M Chertow; Sharon-Lise T Normand; Barbara J McNeil
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

8.  Radiocontrast agents induce endothelin release in vivo and in vitro.

Authors:  S N Heyman; B A Clark; N Kaiser; K Spokes; S Rosen; M Brezis; F H Epstein
Journal:  J Am Soc Nephrol       Date:  1992-07       Impact factor: 10.121

9.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

Authors:  Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

10.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.

Authors:  Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121
View more
  2 in total

1.  Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Authors:  Pengfei Zuo; Yongjun Li; Zhi Zuo; Xin Wang; Genshan Ma
Journal:  Ann Transl Med       Date:  2020-11

2.  The relationship between pre-procedural elevated arterial lactate and contrast-induced nephropathy following primary percutaneous coronary intervention.

Authors:  Jun-Qing Yang; Xiao-Sheng Guo; Peng Ran; Xiang-Ming Hu; Ning Tan
Journal:  J Thorac Dis       Date:  2021-09       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.